NEWARK, Del, June 20, 2023 (GLOBE NEWSWIRE) -- According to a recently published Future Market Insights report, the global Organoids Market is anticipated to flourish at a CAGR of 13% from 2023 to 2033. By the end of the said forecast period, the market is likely to be valued at US$ 205.2 million.
Organoids are microscopic 3D structures that self-organize and are grown in vitro from stem cells. This multipurpose innovation has resulted in the development of several novel human cancer models. Organoids have been increasingly used in a variety of applications, including pathogenesis, disease modelling, regenerative medicine, and drug screening, and this trend is expected to continue.
For Details about Vendors and Their Offerings – Request your Sample Report here @ https://www.futuremarketinsights.com/reports/sample/rep-gb-8106
Developments in research in the field are driving the global Organoids market. Additionally, the growing trend toward personalized medicine is expected to increase the use of Organoids in future decades.
Top Highlights by FMI’s Analysis:
- According to FMI's analysis, the Organoids market developed at a 15.6% CAGR over the previous decade.
- In 2022, the United States held a 46.1% market share.
- In 2022, Japan accounted for a 4.7% percentage of the market.
- The United Kingdom is expected to grow at a CAGR of 12.9% over the period of forecasting.
- In 2022, intestinal Organoids held a market proportion of 37.42%.
“The National Institute of Allergy and Infectious Diseases, which conducts applied and basic research to assess and create therapeutics and examinations through a variety of contracts and research grants. Governments, commercial organizations, and private funding are all sources of R&D spending. This will almost certainly open up new opportunities for market development.” – says an analyst at FMI.
Key Developments in this Market:
- Next&Bio Inc. an enterprise that created an organoid-based accurate therapeutic search and discovery framework, inked a memorandum of understanding (MOU) with the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) on the setting up of an alliance to realize the implementation of innovative precision medicine treatments employing cancer-Organoids in May 2023.
- In April 2023, scientists from the Princess Máxima Centre for Paediatric Oncology and the Hubrecht Institute in the Netherlands reported that Organoids and CRISPR-Cas9 permitted them to acquire more knowledge into the tumors biology and biological ramifications of various changes to DNA in fibrolamellar carcinoma (FLC), a rare form of child's liver cancer.
Major Players are:
- Cellesce Ltd
- DefiniGEN
- Qgel
- Hubrecht Organoid Technology (HUB)
- OcellO B.V.
- STEMCELL Technologies Inc.
- Thermo Fischer Scientific Inc.
- Organovo Holdings Inc.
- Takara Bio Inc.
- Corning Incorporated
- 3Dnamics Inc
Ask for more details About This Market Along With a Detailed Analysis of the Top Regions @ https://www.futuremarketinsights.com/ask-question/rep-gb-8106
More Valuable Insights:
Future Market Insights, in its new offering, presents an unbiased analysis of the global Organoids market presenting a historical analysis from 2018 to 2022 and forecast statistics for the period of 2023 to 2033.
The study reveals essential insights by Product Type (Intestinal Organoids, Hepatic Organoids, Pancreatic Organoids, Colorectal Organoids, Neural Organoids), Application (Bio-banking, Biomedical Research, and Drug Discovery, Regenerative Medicine), End Use & Region.
Key Segmentation:
By Product Type:
- Intestinal Organoids
- Hepatic Organoids
- Pancreatic Organoids
- Colorectal Organoids
- Neural Organoids
- Others
By Application:
- Bio-banking
- Biomedical Research and Drug Discovery
- Regenerative Medicine
- Cancer Research
- Therapeutic Tools
- Others
By End User:
- Biopharmaceutical Companies
- Contract Research Organizations
- Academics and Research Institutes
Table of Content (ToC):
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and Their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyers
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product Type, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product Type, 2023 to 2033
5.3.1. Intestinal Organoids
5.3.2. Hepatic Organoids
5.3.3. Pancreatic Organoids
5.3.4. Colorectal Organoids
5.3.5. Neural Organoids
5.3.6. Others
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033
Buy Now to Gain Access to Detailed Information About Each Segment and Identify Key Trends, Drivers, and Challenges in the Market @ https://www.futuremarketinsights.com/checkout/8106
Have a Look at Related Reports of the Healthcare domain:
Lung Cancer Therapeutics Market Size: The global lung cancer therapeutics market share is projected to reach US$ 48,725.9 Million by 2026, exhibiting a CAGR of 13.4% in the forecast period.
Clinical Research Organization Market Share: According to Future Market Insights (FMI) analysis in a recent market survey, the global clinical research organization market was valued at US$ 58.0 Billion in 2022 and is expected to reach US$ 139.6 Billion by 2033.
Regenerative Medicine Market Demand: According to research, global demand for regenerative medicine will increase by 23.9% per year to US$ 23.43 Billion in 2026.
Nuclear Medicine Equipment Market Analysis: The nuclear medical equipment market is estimated to grow at a stable CAGR of 4.1% between 2022 and 2032.
Preventive Medicine Market Growth: As per FMI Analysts, the global preventive medicine market is estimated to be valued at US$ 372 Billion in 2022 and is projected to increase at a CAGR of 4.8% in the forecast period from 2022 to 2032.
Drug Discovery Enzymes Market Research: The drug discovery enzymes market is likely to be worth US$ 1,776.8 million by 2032, from its projected US$ 886.6 million in 2022.
Drug Discovery Services Market Forecast: According to the research report published by FMI, the global market is anticipated to surpass a valuation of US$ 19.7 billion in 2023. It is likely to hit a valuation of US$ 76.5 billion by 2033. The market is projected to exhibit a captivating CAGR of 14.5% from 2023 to 2033.
Drug Discovery Informatics Market Insights: A newly released Drug Discovery Informatics Market analysis report by Future Market Insights reveals that global sales of the Drug Discovery Informatics Market in 2022 were held at US$ 2.9 billion. With a CAGR of 14.4% from 2023 to 2033, the market is projected to reach a valuation of US$ 12.5 billion by 2033.
Drug Discovery Outsourcing Market Overview: The drug discovery outsourcing market is expected to expand its roots at a steady CAGR of 7.2% during the forecast period. The market is likely to hold a revenue of US$ 3.75 billion in 2023, while it is anticipated to cross a value of US$ 7.52 billion by 2033.
Clinical Research Organization Market Outlook: According to Future Market Insights (FMI) analysis in a recent market survey, the global clinical research organization market was valued at US$ 58.0 Billion in 2022 and is expected to reach US$ 139.6 Billion by 2033.
About Future Market Insights (FMI):
Future Market Insights, Inc. (ESOMAR certified, Stevie Award - recipient market research organization, and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel, and End Use over the next 10 years.
Contact Us:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn | Twitter | Blogs
